THERMO Fisher Scientific Inc. announced March 17 that it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company.
Founded in 1997, Prionics is headquartered in Zurich, Switzerland, and has a major production facility in Lelystad, Netherlands.
Prionics' product line of more than 50 diagnostic test kits, accessories and biochemicals expands the portfolio of animal health testing products under Thermo Fisher Scientific's Life Technologies brand, according to the announcement.
"Prionics adds a unique blend of expertise and diagnostic solutions to new and existing customers," Kirk Adams, Thermo Fisher Scientific global animal health leader, said. "Improved accessibility to animal testing benefits both veterinarians and livestock producers."
The Prionics acquisition adds state-of-the-art infrastructure, a certified tuberculin manufacturing facility, plus additional enzyme-linked immunosorbent assays to the Life Technologies brand.
Thermo Fisher Scientific, with revenues of $17 billion and 50,000 employees in 50 countries, operates four brands — Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services — that offer a combination of innovative technologies, purchasing convenience and comprehensive support.